Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diabetes Mellitus

ClinicalTrials.gov ID: NCT00085969

Public ClinicalTrials.gov record NCT00085969. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 9, 2026, 1:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Triple-Blind, Placebo-Controlled, Multicenter Study to Examine the Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diabetes Mellitus

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the safety and efficacy of a 28-day regimen of exenatide (AC2993), given as a monotherapy to subjects with type 2 diabetes mellitus.

Study identification

NCT ID
NCT00085969
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AstraZeneca
Industry
Enrollment
99 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2003
Primary completion
Dec 31, 2003
Completion
Dec 31, 2003
Last update posted
Feb 22, 2015

2003 – 2004

United States locations

U.S. sites
23
U.S. states
15
U.S. cities
22
Facility City State ZIP Site status
The Whittier Institute for Diabetes La Jolla California 92037
VA Medical Center San Diego California 92161
MedStar Research Institute Washington D.C. District of Columbia 20003
Internal Medicine Associates, Department of Research Fort Myers Florida 33901
Jacksonville Center for Clinical Research Jacksonville Florida 32216
Innovative Research of West Florida Largo Florida 33770
Henry Ford Health System Detroit Michigan 48202
Grand Rapids Associated Internists Grand Rapids Michigan 49506
Radiant Research, Inc. St Louis Missouri 63141
Internal Medicine Associates Bozeman Montana 59715
Mercury Street Medical Group Butte Montana 59701
Lovelace Scientific Resources Las Vegas Nevada 89128
Rochester Clinical Research, Inc. Rochester New York 14609
Metrolina Medical Research Charlotte North Carolina 28209
Piedmont Medical Research Associates Winston-Salem North Carolina 27103
Radiant Research Columbus Ohio 43212
Smith Clinic Research Marion Ohio 43302
Radiant Research Portland Oregon 97239
Philadelphia Health Associates - Adult Medicine Philadelphia Pennsylvania 19146
Diabetes and Glandular Disease Research Associates San Antonio Texas 78229-4801
S.A.M. Clinical Research Center San Antonio Texas 78229
McGuire VA Medical Center Richmond Virginia 23249
Rockwood Clinic Spokane Washington 99202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00085969, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 22, 2015 · Synced Sep 9, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00085969 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →